Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-381-9 | CAS number: 139-89-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1990-01-19
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Trisodium 2-(carboxylatomethyl(2-hydroxyethyl)amino)ethyliminodi(acetate)
- EC Number:
- 205-381-9
- EC Name:
- Trisodium 2-(carboxylatomethyl(2-hydroxyethyl)amino)ethyliminodi(acetate)
- Cas Number:
- 139-89-9
- Molecular formula:
- C10H18N2O7.3Na
- IUPAC Name:
- trisodium [{2-[bis(carboxylatomethyl)amino]ethyl}(2-hydroxyethyl)amino]acetate
- Details on test material:
- - Name of test material (as cited in study report): Trilon D flussig
- Lot/batch No.: B110
- Storage condition of test material: 4 - 8 degrees C
- All other template details: Not reported
Constituent 1
Method
- Target gene:
- his+ revertants
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- - Properly maintained: yes
- Periodically checked for Mycoplasma contamination: no
- Periodically checked for karyotype stability: no
- Periodically "cleansed" against high spontaneous background: yes
- Periodically checked for deep rough character: yes
- Periodically checked for UV sensitivity: yes
- Periodically checked for ampicillin resistance (R factor plasmid): yes - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 mix
- Test concentrations with justification for top dose:
- 0, 20, 100, 500, 2500, 500 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: aqua dest.
- Justification for choice of solvent/vehicle: complete solubility of the test substance in aqua dest.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: with S-9 mix: 2-aminoanthracine (in DMSO); without S-9 mix: N-methyl-N'-nitro-N-nitrosoguianidine (in DMSO) for strains TA 100 and TA 1535; 4-nitro-o-phenylendiamine (in DMSO) for strain TA 98; 9-aminoacridine chloride monohydrate (in DMSO) for TA 1537
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation), test tubes containing 2 mL portions of soft agar (100 ml agar - 0.6% agar + 0.6% NaCl) and 10 mL amino acid solution are kept in a water bath at 45 degrees C. The remaining ingredients were added: 0.1 mL test solution, 0.1 mL bacterial suspension, 0.5 mL S-9 mix (in tests with metabolic activation) or 0.5 ml phosphate buffer (in tests without metabolic activation)
DURATION
- Preincubation period: 20 minutes for that study
- Exposure duration: 48 hours at 37 degrees C
NUMBER OF REPLICATIONS: 3
NUMBER OF CELLS EVALUATED: >10^7 cells
DETERMINATION OF CYTOTOXICITY
- Method: reduced his- background growth
OTHER EXAMINATIONS: No
Other: Tissue preparation for the S-9 fraction (according to Ames et al.)
- 5 male Sprague-Dawley rats (200-300 g) receive a single IP injection of 500 mg Aroclor 1254 per kg BW 5 days before sacrifice
- Rats are sacrificed, livers removed, weighted and washed in a 150 mM KCl solution
- Livers then are cut into small pieces and homogenized in three volumes of KCl solution and centrifuged at 9000 x g for 10 minutes at 4 degrees C
- 5 ml portions of the supernatant are quickly deep-frozen in dry ice and stored at -70 to -80 degrees C for up to 2 months
- S9 mix is prepared freshly prior to each experiment with: MgCl2 - 8 mM, KCl - 33 mM, glucose-S-phosphate - 5 mM, NADP - 4 mM, phosphate buffer (pH 7.4) - 100 mM - Evaluation criteria:
- 1) doubling of the spontaneous mutation rate (control), 2) dose-response relationship, 3) reproducibility of the results
- Statistics:
- Not reported
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not applicable
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Full results provided on Tables 1-4 showing the number of revertants/plate for each strain.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1. Results for Strain TA1535 – Number of Revertants/Plate.
Dose |
without S9 |
Ave. |
SD |
with S9 |
Ave. |
SD |
Negative control Aqua Dest. |
12 |
16 |
4 |
14 |
13 |
1 |
18 |
|
|
12 |
|
|
|
19 |
|
|
13 |
|
|
|
20 |
16 |
15 |
1 |
13 |
15 |
3 |
14 |
|
|
18 |
|
|
|
14 |
|
|
13 |
|
|
|
100 |
15 |
18 |
3 |
13 |
15 |
4 |
20 |
|
|
19 |
|
|
|
18 |
|
|
12 |
|
|
|
500 |
19 |
16 |
3 |
10 |
14 |
5 |
15 |
|
|
20 |
|
|
|
14 |
|
|
12 |
|
|
|
2500 |
15 |
16 |
2 |
14 |
12 |
4 |
19 |
|
|
15 |
|
|
|
15 |
|
|
8 |
|
|
|
5000 |
13 |
14 |
1 |
12 |
14 |
3 |
15 |
|
|
17 |
|
|
|
15 |
|
|
13 |
|
|
|
Pos. Control 2-AA |
|
|
|
130 |
114 |
17 |
|
|
|
96 |
|
|
|
|
|
|
115 |
|
|
|
Pos. Control MNNG |
1880 |
1927 |
64 |
|
|
|
1900 |
|
|
|
|
|
|
2000 |
|
|
|
|
|
Table 2. Results for Strain TA100 – Number of Revertants/Plate.
Dose |
without S9 |
Ave. |
SD |
with S9 |
Ave. |
SD |
Negative control Aqua Dest. |
100 |
105 |
6 |
119 |
112 |
13 |
102 |
|
|
97 |
|
|
|
112 |
|
|
121 |
|
|
|
20 |
124 |
131 |
13 |
137 |
126 |
10 |
123 |
|
|
123 |
|
|
|
146 |
|
|
117 |
|
|
|
100 |
134 |
119 |
14 |
127 |
123 |
9 |
117 |
|
|
129 |
|
|
|
106 |
|
|
113 |
|
|
|
500 |
85 |
85 |
1 |
108 |
111 |
7 |
84 |
|
|
119 |
|
|
|
86 |
|
|
106 |
|
|
|
2500 |
100 |
114 |
12 |
111 |
115 |
4 |
124 |
|
|
116 |
|
|
|
117 |
|
|
118 |
|
|
|
5000 |
124 |
144 |
19 |
133 |
127 |
7 |
146 |
|
|
130 |
|
|
|
162 |
|
|
119 |
|
|
|
Pos. Control 2-AA |
|
|
|
1880 |
1913 |
42 |
|
|
|
1900 |
|
|
|
|
|
|
1960 |
|
|
|
Pos. Control MNNG |
1900 |
2083 |
161 |
|
|
|
2150 |
|
|
|
|
|
|
2200 |
|
|
|
|
|
Table 3. Results for Strain TA1537 – Number of Revertants/Plate.
Dose |
without S9 |
Ave. |
SD |
with S9 |
Ave. |
SD |
Negative control Aqua Dest. |
5 |
8 |
3 |
10 |
12 |
2 |
10 |
|
|
12 |
|
|
|
9 |
|
|
13 |
|
|
|
20 |
12 |
10 |
2 |
22 |
18 |
4 |
10 |
|
|
15 |
|
|
|
9 |
|
|
18 |
|
|
|
100 |
11 |
11 |
1 |
20 |
15 |
6 |
12 |
|
|
9 |
|
|
|
10 |
|
|
15 |
|
|
|
500 |
12 |
11 |
4 |
9 |
11 |
2 |
14 |
|
|
11 |
|
|
|
6 |
|
|
13 |
|
|
|
2500 |
10 |
12 |
6 |
3 |
7 |
5 |
8 |
|
|
12 |
|
|
|
19 |
|
|
5 |
|
|
|
5000 |
7 |
10 |
4 |
8 |
8 |
1 |
14 |
|
|
7 |
|
|
|
10 |
|
|
8 |
|
|
|
Pos. Control 2-AA |
|
|
|
204 |
185 |
19 |
|
|
|
184 |
|
|
|
|
|
|
167 |
|
|
|
Pos. Control MNNG |
558 |
527 |
34 |
|
|
|
532 |
|
|
|
|
|
|
491 |
|
|
|
|
|
Table 4. Results for Strain TA98 – Number of Revertants/Plate.
Dose |
without S9 |
Ave. |
SD |
with S9 |
Ave. |
SD |
Negative control Aqua Dest. |
29 |
30 |
3 |
44 |
44 |
1 |
28 |
|
|
43 |
|
|
|
33 |
|
|
45 |
|
|
|
20 |
34 |
31 |
3 |
44 |
44 |
6 |
31 |
|
|
39 |
|
|
|
29 |
|
|
50 |
|
|
|
100 |
29 |
31 |
4 |
45 |
39 |
5 |
36 |
|
|
36 |
|
|
|
29 |
|
|
37 |
|
|
|
500 |
29 |
31 |
3 |
51 |
42 |
8 |
35 |
|
|
36 |
|
|
|
29 |
|
|
38 |
|
|
|
2500 |
42 |
31 |
12 |
41 |
48 |
6 |
18 |
|
|
52 |
|
|
|
34 |
|
|
52 |
|
|
|
5000 |
28 |
35 |
8 |
45 |
40 |
10 |
34 |
|
|
29 |
|
|
|
44 |
|
|
47 |
|
|
|
Pos. Control 2-AA |
|
|
|
1460 |
1447 |
160 |
|
|
|
1280 |
|
|
|
|
|
|
1600 |
|
|
|
Pos. Control MNNG |
800 |
815 |
19 |
|
|
|
836 |
|
|
|
|
|
|
810 |
|
|
|
|
|
Applicant's summary and conclusion
- Conclusions:
- There was no increase in the number of mutations (his+ revertants) in bacterial strains TA 1535, TA 100, TA 1537, and TA 98 exposed to 20-5000 ug/plate of the test material in agar for 48 hours. The test material did not appear to be cytotoxic. There was an appropriate response from the positive control materials.
- Executive summary:
An increase in the number of his+ revertants was not observed both in the standard plate test and in the pre-incubation test either without S-9 mix or after the addition of a metabolizing system to strains TA 1535, TA 100, TA 1537, and TA 98 from 20 -5000 ug/plate of Trilon D. According to the results of the present study, the test substance Trilon D flussig is not mutagenic in the Ames test under the experimental conditions chosen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.